Projects per year
Personal profile
Research interests
Dr. Thonhoff’s research focuses on the role of regulatory T cells (Tregs) in ALS. The loss of Treg function is associated with acceleration of disease progression in ALS. Dr. Thonhoff is exploring the mechanisms through which Treg function is lost in ALS and potential therapies aimed to enhance the neuroprotective function of Tregs. He is also investigating the use of autologous Treg infusions as a therapy for patients with ALS. In addition, he is involved in several clinical trials investigating novel treatments for patients with Myasthenia Gravis, Myotonic Dystrophy and CIDP.
Research Area Keywords
- Neurosciences
- Immunobiology & Inflammation
Free-text keywords
- Neuromuscular disorders
- Neurodegenerative diseases
- Amyotrophic Lateral Sclerosis (ALS)
- Myasthenia Gravis
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Muscular Dystrophy
- Cellular and genetic therapies
- Neuroinflammation
Fingerprint
Dive into the research topics where Jason R. Thonhoff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Phase 2a_AT-1501_ALS AT-1501-A201
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
10/30/20 → …
Project: Clinical Trial
-
Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
Shroff, S., Appel, S. H., Greene, E. P. & Thonhoff, J. R.
10/20/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen A Zilucoplan
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
8/20/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
8/19/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen B Verdiperstat
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
8/19/20 → …
Project: Clinical Trial
Research Output
-
Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis
Beers, D. R., Zhao, W., Neal, D. W., Thonhoff, J. R., Thome, A. D., Faridar, A., Wen, S., Wang, J. & Appel, S. H., Dec 1 2020, In : Scientific Reports. 10, 1, 15295.Research output: Contribution to journal › Article
Open Access -
Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of Patients with ALS and Healthy Controls
Zhao, W., Beers, D. R., Thonhoff, J. R., Thome, A. D., Faridar, A., Wang, J., Wen, S., Ornelas, L., Sareen, D., Goodridge, H. S., Svendsen, C. N. & Appel, S. H., Jun 26 2020, In : iScience. 23, 6, 101192.Research output: Contribution to journal › Article
1 Scopus citations -
Increased activation ability of monocytes from ALS patients
Du, Y., Zhao, W., Thonhoff, J. R., Wang, J., Wen, S. & Appel, S. H., Jun 1 2020, In : Experimental Neurology. 328, 113259.Research output: Contribution to journal › Article
2 Scopus citations -
Expanded autologous regulatory T-lymphocyte infusions in ALS A phase I, first-in-human study
Thonhoff, J. R., Beers, D. R., Zhao, W., Pleitez, M., Simpson, E. P., Berry, J. D., Cudkowicz, M. E. & Appel, S. H., Jul 1 2018, In : Neurology: Neuroimmunology and NeuroInflammation. 5, 4, p. e465 e465.Research output: Contribution to journal › Article
40 Scopus citations -
Functional alterations of myeloid cells during the course of Alzheimer's disease
Thome, A. D., Faridar, A., Beers, D. R., Thonhoff, J. R., Zhao, W., Wen, S., Pascual, B., Masdeu, J. C. & Appel, S. H., Nov 13 2018, In : Molecular Neurodegeneration. 13, 1, p. 61 1 p.Research output: Contribution to journal › Article
8 Scopus citations